NWPF

News ArchivesRead News

Eye implants offer Parkinson’s hope

Thursday December 15, 2005

Wai Lang Chu

12/13/05(Archives of Neurology) - A new therapy for Parkinson’s disease involving brain implants has been developed by US scientists, who believe this new treatment is a viable alternative to drugs currently used to treat this chronic irreversible brain condition.

Levodopa is currently the most common drug treatment for the brain condition but the pills can leave people susceptible to involuntary movements such as twitches. It is normally prescribed a few years after diagnosis as the symptoms get worse.

In addition, disease progression and long-term oral treatment with levodopa may lead to the development of motor fluctuations and dyskinesias

This new approach involved taking levadopa producing eye cells taken from a dead donor and implanting the directly into the brains of six Parkinsons patients. The researchers reported no serious side effects.

Eye cells that form retinal pigment epithelial tissue produce levodopa and can be isolated from human eye tissue and implanted in the brain. Research on animals has shown that the cell implants can help treat the symptoms safely.

The retina cells were cultivated and implanted in the brains of six patients with advanced Parkinson’s, said researcher Natividad Stover of the University of Alabama.

One year later, the patients scored 48 per cent higher on tests of movement and coordination, and the improvement was sustained after two years, Stover wrote in the report.

"The implants were well tolerated," the report said. "Improvement was also observed in activities of daily living (and) quality of life."

The study is additional proof that the technique could work on humans and paves the way for a larger, more thorough study.

Indeed, Stover added that a randomised, double-blind, placebo-controlled study was now in the pipeline to test the treatment further.

For most patients, the levodopa pills lose their effectiveness over five years or less, and larger and larger doses are needed to keep at bay the involuntary movements and shaking symptomatic of the disease.

Some scientists have viewed implanting foetal stem cells into the brains of Parkinson’s patients as a promising avenue to restoring dopamine production. But preliminary human trials were disappointing, and animal experiments have yielded mixed results.

Other treatments showing promise include deep brain stimulation with implanted electrodes, drugs that promote brain cell growth, and gene therapy

Recent News

Jul 24 - Parkinson's: Mutant gene interaction may pave the way for new treatments
Jul 22 - Boxing training used to fight against Parkinson's disease
Jul 17 - Stem cell treatment breakthrough could cure Parkinson’s patients
Jul 14 - Cancer drug shows early promise for Parkinson's disease
Jul 13 - Opinion: Dividing the Caregiving Responsibilities Between Siblings
Jul 12 - Researchers make advance in possible treatments for Gaucher, Parkinson’s diseases
Jul 11 - Parkinson’s Head Trauma Link Looks Even Stronger
Jul 7 - Penn students’ start-up XEED puts wearables to work against Parkinson’s disease
Jul 5 - Last Patient Enrolled in Pivotal Phase 3 Parkinson’s Disease Trial, Cynapsus Therapeutics Says
Jun 29 - Exoskeleton Could Quell the Tremors of Parkinson's Disease Patients at Crucial Moments
Jun 28 - Parkinson's disease: New protein discovery could fuel new treatments
Jun 27 - Study finds direct evidence linking Parkinson’s to autoimmune disease; 2 genes that are key regulators of immune system discovered
Jun 27 - Blocking key enzyme halts parkinson's disease symptoms in mice
Jun 23 - Parkinson's Research Might Benefit from Novel Discovery of Zinc Transport Protein Structure
Jun 23 - Parkinson's disease breakthrough 'could lead to cure'
Jun 20 - More American men diagnosed with Parkinson's
Jun 15 - First monkey genetically engineered to have Parkinson’s created
Jun 14 - Fighting Parkinson's in the lab
Jun 9 - A New Gene Has Been Linked to Parkinson's Disease
Jun 6 - A neurologist weighs in on Muhammad Ali's battle with Parkinson's disease